SII stopped manufacturing Covishield since December 2021, says 'disclosed side effects details in packaging insert'
Wednesday, 8 May 2024
SII stopped Covishield extra doses due to lawsuit, disclosed rare Thrombosis. Advocates govt collaboration. AstraZeneca withdraws Vaxzevria marketing authorisations globally. European Medicines Agency confirms Vaxzevria discontinuation in EU.
SII stopped Covishield extra doses due to lawsuit, disclosed rare Thrombosis. Advocates govt collaboration. AstraZeneca withdraws Vaxzevria marketing authorisations globally. European Medicines Agency confirms Vaxzevria discontinuation in EU.
|
||||
💡 newsR Knowledge: Other News MentionsYou Might Like |